Akoya Biosciences, Inc. (AKYA)

Jul 8, 2025 - AKYA was delisted (reason: acquired by QTRX)

1.290

0.00 (0.00%)

Inactive · Last trade price on Jul 7, 2025

Akoya Biosciences Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	79.96	81.67	96.63	74.86	54.92	42.44
Revenue Growth	-14.55%	-15.48%	29.09%	36.31%	29.39%	0.49%
Gross Profit	49.37	47.88	56.31	43.39	34.22	25.91
Operating Income	-37.41	-41.18	-56.03	-66.21	-37.23	-11.49
Net Income	-47.53	-55.37	-63.32	-70.64	-44.37	-21.76
Earnings Per Share	-0.96	-1.12	-1.43	-1.87	-1.65	-9.18
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Instruments	42.1	38.64	28.69	23.77	26.47
Service and Other	29.22	17.21	10.44	9.01	5.89
Consumables	24.13	18.38	14.3	8.54	8.17
Standalone Software	1.18	0.64	1.49	1.13	1.71

Cash & Debt

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Investments	27.54	35.04	83.13	81.22	113.08	17.01
Total Debt	83.72	84.15	85.71	75.78	32.94	34.99
Net Cash (Debt)	-56.18	-49.11	-2.58	5.43	80.14	-17.99
Net Cash Growth	-	-	-	-93.22%	-	-
Net Cash Per Share	-1.13	-0.99	-0.06	0.14	2.98	-7.59

Cash Flow & CapEx

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Cash Flow	-30.49	-44.1	-50.9	-53.5	-36.07	-6.84
Capital Expenditures	-1.85	-2.46	-3.65	-7.36	-5.09	-3.3
Free Cash Flow	-32.34	-46.56	-54.55	-60.86	-41.16	-10.14
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Gross Margin	61.74%	58.62%	58.27%	57.96%	62.31%	61.04%
Operating Margin	-46.79%	-50.43%	-57.98%	-88.44%	-67.78%	-27.08%
Pretax Margin	-59.28%	-67.61%	-65.49%	-94.20%	-78.44%	-39.26%
Profit Margin	-59.45%	-67.79%	-65.53%	-94.36%	-80.79%	-51.27%
FCF Margin	-40.45%	-57.01%	-56.45%	-81.29%	-74.95%	-23.89%

Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '26 Aug 10, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
PS Ratio	0.80	1.39	2.48	4.85	10.37	-